P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer via Wnt/β-catenin signal pathway.
The effect of hepatitis C virus p7 trans-regulated protein 3 (P7TP3) in the development of hepatocellular carcinoma (HCC) is still unknown. This study aimed to investigate the role and mechanism of P7TP3 in HCC. P7TP3 was significantly decreased in HCC tissues when compared with corresponding liver tissues just around the tumor (LAT) from 7 HCC patients. Fewer and smaller colonies were originated from HepG2-P7TP3 cells when compared to HepG2-NC cells. Overexpression of P7TP3 in HepG2 cells has significantly repressed the growth of HCC xenografts in nude mice. Furthermore, wound-healing tests, transwell assays, matrigel transwell assays, adhesion assays, CCK-8 assays, flow cytometry and western blotting analysis revealed that P7TP3 protein expression inhibited migration, invasion, adhesion, proliferation and cell cycle progression in HCC cell lines. Moreover, P7TP3 suppressed the activity of Wnt/β-catenin signaling pathway, and was restored by Wnt3a, which is an activator of Wnt/β-catenin signaling pathway. Consistently, β-catenin was highly expressed by P7TP3 silencing, and restored by XAV939, an inhibitor of Wnt/β-catenin signaling pathway. Finally, miR-182-5p suppressed the expression of target gene P7TP3 by directly interacting with 3'-UTR region. Taken together, P7TP3, the direct target gene of miR-182-5p, inhibited HCC by regulating migration, invasion, adhesion, proliferation and cell cycle progression of liver cancer cell via Wnt/β-catenin signaling pathway. These findings provide strong evidence that P7TP3 acts as a new promising tumor suppressor in HCC.